Efficacy assessment of cell therapy in skin aging
Phase 3
- Conditions
- atrophic disorders of skin (aging).Atrophic disorder of skin, unspecified
- Registration Number
- IRCT2014100719432N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
age about 35 to 55 years old;
Having no anatomic disorder in face;
Wrinkle type between grade 2 to 4;
Normal mental health;
Having a good cooperation with research team;
Exclusion criteria:
being smokers or drinkers;
any past skin intervention in face;
Having many wrinkles on the face;
type of 1 or 5 of wrinkle scoring;
having a mental disorder;
having an obsessed disorder;
having any skin disorder;
having any major disorder;
having a systemic disorder;
having an oral disorder;
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantity of nasolabial fold wrinkle - Extension. Timepoint: 1- 3 - 6 Month after cell therapy. Method of measurement: Biometry with visioface & skin sonography.;Quality of nasolabial fold wrinkle - deep. Timepoint: 1 - 3 - 6 Mounth after intervention. Method of measurement: Visio face & skin sono.
- Secondary Outcome Measures
Name Time Method Color. Timepoint: 1 - 3 - 6 Month after cell therapy. Method of measurement: Biometry with colorimeter.;Elastisity. Timepoint: 1 - 3 - 6 Eounth after intervention. Method of measurement: MPA 9.